Bladder Cancer Research Network

Recognizing the need to more aggressively engage the research community, BCAN created the BCRN–the Bladder Cancer Research Network— the cornerstone of our research mission.  This division is led by members of the Management Committee, comprised of leading doctors and scientists representing all aspects of bladder cancer research, including urology, medical oncology, basic science, pathology, radiation oncology and population science.

Rick Bangs BCAN patient advocate

John L. Gore, MD, MS University of Washington, Seattle, WA

William Y. Kim, MD UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC

Anne E. Kiltie, MD  Oxford University, United Kingdom

Seth Lerner, MD, FACS  Baylor College of Medicine – Houston, TX

Yair Lotan, MD  UT Southwestern Medical Center – Dallas, TX

David J. McConkey, PhD  Johns Hopkins Medical Institutions – Baltimore, MD

James McKiernan, MD Columbia Presbyterian Hospital, New York, NY

Gerald McNamara BCAN Board of Directors, New York, NY

Matthew I. Milowsky, MD  UNC Lineberger Comprehensive Cancer Center – Chapel Hill, NC

Elizabeth Plimack, MD  Fox Chase Cancer Center, Philadelphia, PA

Jonathan Rosenberg, MD   Memorial Sloan-Kettering Cancer Center, New York, NY

Eila Skinner, MD  Stanford University – Stanford, CA

Gary D. Steinberg, MD, FACS  Rush University Medical Center – Chicago, IL

John A. Taylor, III, MD, MS University of Kansas – Kansas City, KS

Diane Zipursky Quale  Co-Founder – Washington DC